also "We have completed studies for MANF in an
Post# of 30028
Quote:
"We have completed studies for MANF in an undisclosed orphan indication"
when asked about Novartis working on MANF DB-2 Gerald basically stated that although he was aware of it, he could not comment...
not hyping here - but hoping - Novartis is behind this undisclosed Orhpan